59 related articles for article (PubMed ID: 1256687)
1. [Controlled clinical trial of 2-mercapto-propionyl-glycine in chronic hepatopathies].
Dioguardi N; Ideo G; De Franchis R; Ronchi G
Minerva Med; 1976 Mar; 67(11):676-81. PubMed ID: 1256687
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of hepatic diseases with alpha-mercaptopropionylglycine].
De Pergola E; Carrozzini B; Selvaggio G; De Pergola G
Minerva Med; 1982 May; 73(19):1297-9. PubMed ID: 7078808
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the liver cell clearance fraction before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
Cortinovis A; Paolini FA; Crippa A
Arch Sci Med (Torino); 1979; 136(4):497-508. PubMed ID: 550750
[TBL] [Abstract][Full Text] [Related]
4. [Study of changes in certain immunoglobulin fractions in acute and chronic hepatopathies treated with alpha-mercaptopropionylglycine].
Marinai E; Ulivieri P; Righi A
Minerva Med; 1977 Dec; 68(62):4193-7. PubMed ID: 600464
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the changes in some laboratory parameters in liver disease patients treated with Toxepasi Complex].
Lenzi S
Minerva Med; 1976 Sep; 67(46):2961-74. PubMed ID: 967362
[TBL] [Abstract][Full Text] [Related]
6. [Histological and ultramicroscopic aspects of the small intestine in aregenerative enteropathies after treatment with 2-mercapto-propionyl-glycine (Thiola)].
Labò G; Gasbarrini G; Barbara L; Fontana G; Corazza GR
Minerva Med; 1977 Jul; 68(36):2491-8. PubMed ID: 887228
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of acute and chronic liver disease as well as several malabsorption syndromes with 2 mercaptopropionylglycine MPG (thiola) (author's transl)].
Markoff NG
Schweiz Rundsch Med Prax; 1975 Jul; 64(30):958-61. PubMed ID: 1144310
[No Abstract] [Full Text] [Related]
8. [Effect of 2 mercaptopropionylglycine on the cytotoxic activity of lymphocytes from patients with chronic active hepatitis against rabbit hepatocytes isolated and cultured in vitro].
Mazzetti M; Guizzardi G; Meliconi R; Baraldini M; Stancari MV; Mazzoli M; Stefanini GF
Boll Soc Ital Biol Sper; 1981 Jul; 57(14):1477-83. PubMed ID: 7295410
[TBL] [Abstract][Full Text] [Related]
9. [Double-blind studies of the therapeutic action of S-Adenosylmethionine (SAMe) in oral administration, in liver cirrhosis and other chronic hepatitides].
Miglio F; Stefanini GF; Corazza GR; D'Ambro A; Gasbarrini G
Minerva Med; 1975 May; 66(33):1595-9. PubMed ID: 1095965
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the fraction of hepatocyte depuration before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
Cortinovis A; Paolini FA; Crippa A
Minerva Med; 1979 Dec; 70(54):3709-13. PubMed ID: 523002
[No Abstract] [Full Text] [Related]
11. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
[TBL] [Abstract][Full Text] [Related]
12. The effects of MPG (2-mercapto-propionyl-glycine) in atrophic enteritis and aregenerative enteropathies.
Labò G; Gasbarrini G; Barbara L; Fontana G; Corazza GR
Panminerva Med; 1977; 19(4):227-35. PubMed ID: 593700
[No Abstract] [Full Text] [Related]
13. [Clinical aspects of cystinuria and its treatment by thiola (author's transl)].
Zechner O; Latal D; Gründig E; Müller M
Wien Klin Wochenschr; 1976 Feb; 88(3):101-5. PubMed ID: 960706
[TBL] [Abstract][Full Text] [Related]
14. [The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment].
Surrenti C; Arcangeli A; Casini A
Minerva Med; 1978 Dec; 69(61):4251-6. PubMed ID: 733081
[TBL] [Abstract][Full Text] [Related]
15. [Tiopronine, new anti-rheumatic drug, has slow action in rheumatoid arthritis].
Amor B; Mery C; de Gery A
Rev Rhum Mal Osteoartic; 1980 Mar; 47(3):157-62. PubMed ID: 7384724
[TBL] [Abstract][Full Text] [Related]
16. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
18. Serum gamma-glutamyl transpeptidase: its clinical significance.
Pár A; Mestyán I; Kádas I; Balázs M; Gógl A
Acta Med Acad Sci Hung; 1976; 33(4):309-19. PubMed ID: 23644
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy in chronic liver disease.
Sherlock S
Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
[TBL] [Abstract][Full Text] [Related]
20. [Relations between protidopoiesis and biological transmethylations: action of S-adenosylmethionine on protein crasis in chronic hepatopathies].
Cantoni L; Maggi G; Mononi G; Preti G
Minerva Med; 1975 May; 66(33):1581-9. PubMed ID: 1095963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
